In this study, we have demonstrated the ability of melanoma cells to diminish iNKT cell cytotoxicity by down-regulating the expression of perforin, granzyme, and NKG2D, while increasing the percentage of iNKT cells expressing FasL. This evidence concerns the gene KLRK1 and melanoma.